EQUITY RESEARCH MEMO

Shimadzu Medical Systems (7701.T)

Generated 4/27/2026

Executive Summary

Conviction (model self-assessment)60/100

Shimadzu Medical Systems, the medical division of Shimadzu Corporation (TSE: 7701.T), is a leading Japanese manufacturer of advanced diagnostic imaging equipment. The company offers a comprehensive portfolio including angiography systems, fluoroscopy equipment, mobile C-arms, radiography systems, mobile X-ray units, and PET imaging systems. With over 1,000 employees and a strong R&D focus, Shimadzu leverages its heritage in precision instrumentation to deliver innovative solutions for interventional radiology, oncology diagnostics, and general radiography. The division operates as a commercial-stage public entity, serving hospitals and clinics globally, with a particular strength in the Japanese domestic market.

Upcoming Catalysts (preview)

  • Q3 2026Launch of next-generation angiography system with AI-enhanced imaging capabilities75% success
  • Q4 2026Expansion of PET/CT product line into emerging markets in Asia and Europe65% success
  • H1 2027Strategic partnership with an AI diagnostics firm to integrate machine learning into X-ray and fluoroscopy workflows60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)